Novo Nordisk is set to acquire German miRNA blocker specialist Cardior Pharmaceuticals GmbH for up to...
Up To Date
Latest News
Researchers at NDM Pharma A/S and Aarhus University have demonstrated that their oral CIC-1 blocker NMD670...
Basel-headquartered Roche AG has inaugurated a brand new €90m gene therapy development centre in Penzberg near...
British pharma giant AstraZeneca has announced to acquire radio-conjugate specialist Fusion Therapeutics Inc...
Exeter-based university spin-out Senisca Ltd has added £3.7m seed money to a £1.1m not dilutive funding to...
French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.